AzTrials
AzTrials

Lumbar Spinal StenosisNCT06719037

Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis

A study testing Endo-Surgi Plus endoscopic surgery, Unilateral biportal endoscopic surgery and Microdiscectomy in people with Lumbar Spinal Stenosis, run by Qilu Hospital of Shandong University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to conduct a multicenter comparison of the clinical efficacy of Endo-Surgi Plus endoscopic technique, UBE endoscopic technique, and microdiscectomy technique in the treatment of lumbar spinal stenosis, and to compare the differences in the incidence of complications, surgical trauma, and… Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Lumbar Spinal Stenosis
What is being tested?
Endo-Surgi Plus endoscopic surgery, Unilateral biportal endoscopic surgery and Microdiscectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
324 participants
Where
1 siteChina
Study dates
8 Dec 2024to 1 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with single-segment lumbar spinal stenosis through CT and MRI imaging combined with clinical symptoms;
  • Symptoms in the lumbar region and lower extremities corresponding to the imaging findings;
  • Patients who have not responded to three months of conservative treatment;
  • Informed consent from family members regarding the surgical procedure and associated risks.

Who cannot join

  • Patients with multi-segment lumbar disc herniation, malignant spinal tumors, spinal deformities, and other diseases.
  • Patients with comorbidities such as cardiovascular diseases, cerebrovascular diseases, or those with mental abnormalities, communication difficulties, or other issues that may affect clinical evaluation.
  • Patients with a history of previous lumbar surgery.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Xinyu Yang, M.D. contact

+8618560089496

dr_xinyuyang@163.com

China1 site, 1 recruiting
  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012

    Xinyu Yang, 8618560089496, dr_xinyuyang@163.com

    Xinyu Yang, M.D.

    Recruiting

Other trials in China

About this study

Official title: Efficacy and Safety of Endo-Surgi Plus Endoscopy, UBE Endoscopy, and Microdiscectomy Decompression Techniques for the Treatment of Lumbar Spinal Stenosis: A Prospective Multicenter Study

The purpose of this study is to conduct a multicenter comparison of the clinical efficacy of Endo-Surgi Plus endoscopic technique, UBE endoscopic technique, and microdiscectomy technique in the treatment of lumbar spinal stenosis, and to compare the differences in the incidence of complications, surgical trauma, and other aspects among the three surgical techniques for the treatment of lumbar spinal stenosis.

Each group of patients received either Endo-Surgi Plus endoscopy, UBE, or microdiscectomy decompression through the Quadrant channel. All patients were routinely administered low-dose hormones, dehydrating agents, and neurotrophic drugs postoperatively. Patients were required to strictly avoid strenuous activities and heavy lifting in the lumbar region for three months after surgery. Upon discharge, patients were provided with the same lumbar and back muscle rehabilitation exercises and other postoperative recovery-related discharge education. Each group of patients was followed up for at least one year, with follow-up including outpatient visits, physical examinations, questionnaire scoring, and necessary auxiliary examinations.

Both two endoscopic surgeries, as surgical techniques that have been used in clinical practice for many years, have their efficacy confirmed by various studies. The investigator proposes that these two techniques may have similar clinical efficacy to microdiscectomy, while also offering the advantage of being less invasive. The aim of this study is to validate these assumptions. At the same time, there may be some differences between the two endoscopic surgeries that require further verification.

Read the detailed description

The lumbar spine is the part of the spine that bears the most weight, consisting of five vertebrae. Each vertebra is connected by an intervertebral disc, and together they form a barrier to protect the spinal cord nerves within the spinal canal. Lumbar spinal stenosis refers to the reduction of space within the lumbar spinal canal, which compresses the spinal cord or nerve roots, leading to a series of symptoms. Depending on the cause, lumbar spinal stenosis is mainly divided into congenital lumbar spinal stenosis, which is due to abnormal development of the spinal canal, and acquired lumbar spinal stenosis, which is caused by degenerative changes such as lumbar disc degeneration and joint process hyperplasia. Lumbar spinal stenosis is a common cause of low back and leg pain, with a reported incidence rate as high as 11% in the general population and 19.4% in those over 60 years old, with a trend of increasing with age. With the aging of the population, the incidence of lumbar spinal stenosis is also on the rise.

The treatment of lumbar spinal stenosis mainly includes conservative treatment and surgical treatment. For patients whose symptoms severely affect their lives and do not respond well to conservative treatment, surgery should be performed as soon as possible to relieve nerve compression. The main goal of surgical treatment for lumbar spinal stenosis is to relieve nerve compression, stabilize the spine, and restore the normal volume of the spinal canal. Although traditional posterior lumbar decompression surgery can achieve definite decompression effects, it has issues such as severe destruction of posterior column structures and large surgical trauma. Minimally invasive techniques are a hot topic in various clinical fields, and microdiscectomy (MD) through a minimally invasive channel is a mature minimally invasive technique for treating lumbar spinal stenosis. As early as 1999, prospective randomized controlled studies confirmed that it has the same excellent clinical efficacy as open surgery but with less surgical trauma. It has now become a classic surgical method for treating lumbar spinal stenosis, with related articles published in the top spinal clinical journal JBJS.

In recent years, with the development of new equipment, endoscopic techniques have been gradually applied to the treatment of lumbar spinal stenosis. Unilateral biportal endoscopic discectomy (UBE) has the characteristics of convenient operation and flexibility because its endoscopic channel and working channel are separate and can use traditional open instruments. It can achieve good decompression effects and has been widely used in various medical centers. Percutaneous endoscopic lumbar discectomy (PELD), as a new generation of endoscopic technique, has less surgical trauma and shorter operation time. It has also been successfully applied to the clinical treatment of lumbar spinal stenosis and achieved good results. However, due to the limitations of the single-endoscopic channel field of view, its learning curve is steep, the surgical difficulty is high, and it is difficult to achieve complete decompression for bilateral spinal stenosis or dorsal nerve root compression. The efficiency of dealing with bony stenosis structures during surgery is low, leading to longer operation time and increased risk of nerve root and dural sac injury. Many clinical studies have compared the advantages and disadvantages of endoscopic techniques with traditional minimally invasive techniques and different endoscopic techniques, concluding that various endoscopic techniques can achieve surgical efficacy similar to traditional techniques with the advantages of less surgical trauma and faster postoperative recovery. Guilherme et al. believe that PELD has similar clinical efficacy to MD, but MD is superior for complex foraminal stenosis. In addition, a review by Ohyuk et al. suggests that UBE has better clinical efficacy and a lower complication rate compared to MD or PELD. However, most of these studies are small-scale, single-center, and retrospective, and the conclusions lack high-quality evidence support.

In recent years, single-channel decompression techniques under endoscopy have developed rapidly, especially large-channel endoscopes and related tools, which have significantly improved work efficiency and surgical safety. Many hospitals and medical research centers have introduced the Endo-Surgi Plus working channel, which has a larger working tube than traditional endoscopes, making it easier to treat certain types of lumbar disc herniation and lumbar spinal stenosis, further optimizing spinal endoscopic surgery techniques for lumbar spinal stenosis.

With the development of surgical instruments and approaches, these three minimally invasive spinal canal decompression techniques can effectively relieve pain symptoms in patients with various types of lumbar spinal stenosis. Compared with traditional open surgery, these techniques have reduced operation time, intraoperative blood loss, and postoperative pain. However, there are slight differences in the degree of trauma and ease of operation among these three techniques. Currently, there is still a lack of prospective validation of the clinical efficacy of these surgical techniques internationally, and the advantages and disadvantages of different endoscopic surgeries compared to traditional fenestration surgery.The purpose of this study is to conduct a multicenter comparison of the clinical efficacy of Endo-Surgi Plus endoscopic technique, UBE endoscopic technique, and microdiscectomy technique in the treatment of lumbar spinal stenosis.

Subjects were randomly divided into the Endo-Surgi Plus endoscopy group, the UBE group, and the fenestration group through the Quadrant channel. Randomization (1:1:1 grouping) was conducted within 2 weeks before surgery. Investigators used a block randomization design, stratified by 23 hospitals, with non-competitive enrollment between hospitals. The blocks were kept as small as possible (randomly selected block sizes of 3 and 6) to ensure that each hospital performed a similar number of all three types of surgeries. The computer-generated allocation output was sent via email to the local study coordinators (CRC), who did not participate in patient recruitment or treatment.

Due to the nature of the interventions, double blinding was not feasible. Randomization of patients aimed to reduce potential biases in preoperative planning and patient treatment. Throughout the study, outcome assessors and data analysts remained blinded to reduce biases in clinical outcome assessment and data analysis. Patients were informed that no treatment regimen was recorded as superior to another.

Determination of Sample Size: This study is a randomized controlled trial, with the postoperative 1-year ODI score of the subjects as the main outcome indicator. The trial required 324 patients to be included in total, with 80% statistical power to detect a difference of at least 12 points in ODI scores between treatment groups at a significance level of 0.05.Investigators conservatively chose a difference of 12 points because the U.S. Food and Drug Administration suggests that a 15-point reduction in ODI score indicates a minimally important improvement after spinal fusion surgery. Investigators conservatively set the standard deviation of the ODI score to 18, and estimated a dropout rate of 15%. Finally investigators used PASS to estimate that the trial would need to include a total of 324 patients.

Statistical and Analytical Plan: Patients who underwent the designated surgery and completed at least one year of follow-up were included. For continuous data that met normal distribution, analysis of variance (ANOVA) and post-hoc tests were used to compare differences among the three treatment groups; otherwise, the Kruskal-Wallis H-test was applied. Categorical variables were analyzed using chi-square or Fisher's exact test (expressed in numbers and percentages) to compare baseline characteristics among groups.

A mixed-effects model for repeated measures was used to compare changes in ODI and SF-36 scores relative to baseline across groups. Considering the correlation of repeated measures within patients, an unstructured covariance matrix was specified. The model included fixed effects for treatment (Endo-Surgi Plus endoscopy, UBE, minimally invasive fenestration), time (2 days, 1 month, 3 months, 1 year postoperatively), and time-treatment interaction, with results reported as least squares means and 95% confidence intervals. Robust standard errors and test statistics were calculated for the fixed effects. Appropriate comparisons were made within the mixed-effects model for repeated measures to compare least squares means between treatment groups at each time point and within each treatment group across time points. Considering the various etiologies of lumbar spinal stenosis such as disc degeneration, ligamentum flavum hypertrophy, and bone hyperplasia, this study will perform multivariate adjustments and subgroup analyses based on etiology. All analyses were conducted using R software version 4.3.3, primarily utilizing the lme4 and emmeans packages. A P-value of less than 0.05 was considered statistically significant.

Being tested
Endo-Surgi Plus endoscopic surgery, Unilateral biportal endoscopic surgery, Microdiscectomy
Keywords
Microdiscectomy, Endoscopic, Unilateral Biportal Endoscopic, Endo-surgi Plus endoscopy, ODI, Complication, CK-MB
Medical subject headings
Spinal Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endo-Surgi Plus endoscopic surgeryProcedure or surgery

    Endo-Surgi Plus endoscopic surgery, as a new type of percutaneous endoscopic lumbar discectomy (PELD), features a larger working channel and represents an optimized single-channel endoscopic technique. However, it still has the limitations inherent in single-channel endoscopy.

  • Unilateral biportal endoscopic surgeryProcedure or surgery

    Unilateral biportal endoscopic discectomy (UBE) is characterized by its separate endoscopic and working channels, and the ability to use traditional open instruments, making it a convenient and versatile technique. It is a commonly used spinal endoscopic surgery in clinical practice.

  • MicrodiscectomyProcedure or surgery

    Microdiscectomy (MD) is a mature minimally invasive technique that uses a microscope to treat lumbar spinal stenosis. As early as 1999, prospective randomized controlled studies confirmed that it has equally excellent clinical efficacy compared to open surgery, with less surgical trauma. It is currently the classic minimally invasive surgical approach for treating lumbar spinal stenosis.

Study groups in NCT06719037
Study groupRoleWhat they receive
Endo-Surgi Plus endoscopic groupExperimentalNot described
Receives: Procedure: Endo-Surgi Plus endoscopic surgery
Unilateral biportal endoscopic groupExperimentalNot described
Receives: Procedure: Unilateral biportal endoscopic surgery
Microdiscectomy groupActive comparatorNot described
Receives: Procedure: Microdiscectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Oswestry Disability Index scores

    The maximum score is 100 points, and the minimum score is 0 points. The higher the score, the more severe the functional impairment.

    Measured: 1 year postoperatively

Secondary outcomes (10)
  1. The Oswestry Disability Index scores

    The maximum score is 100 points, and the minimum score is 0 points. The higher the score, the more severe the functional impairment.

    Measured: preoperatively, 1 day, 3 months, and 6 months postoperatively

  2. Visual Analogue Score for lower limb pain/lumbar back pain

    The maximum score is 10 points, and the minimum score is 0 points. A higher score means a worse outcome and a more severe pain.

    Measured: preoperatively, 1 day, 3 months, 6 months, and 1 year postoperatively

  3. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36 score)

    The scales was divided into 9 parts. For each part, the maximum score is 100 points, and the minimum score is 0 points. A higher score means the better outcome.

    Measured: preoperatively, 1 day, 3 months, 6 months, and 1 year postoperatively

  4. Dural sac cross-sectional area calculated from lumbar MRI

    The Dural sac cross-sectional area (DCSA) refers to the two-dimensional area enclosed by the outer boundary of the dural sac as seen on imaging, typically measured in square millimeters (mm²). A reduced DCSA is often used to diagnose spinal stenosis.

    Anterior Boundary: The posterior longitudinal ligament and the vertebral body or intervertebral disc.

    Posterior Boundary: The inner surface of the ligamentum flavum or the posterior vertebral arch.

    Lateral Boundary: The inner walls of the pedicles or the edges of the vertebral foramen.

    These boundaries are identified on axial MRI imaging. The increase rate of the postoperative dural sac cross-sectional area at the last follow-up would be also calculated using Image J, which was defined as the [(postoperative dural sac cross-sectional area - preoperative dural sac cross-sectional area) / preoperative dural sac cross-sectional area].

    Measured: preoperatively and at 1 year postoperatively

  5. Creatine kinase-MB (CK-MB)

    preoperative and immediate postoperative changes in creatine kinase-MB (CK-MB)

    Measured: preoperative and immediate postoperative

  6. Surgery time

    Measured: Immediate postoperatively

  7. Intraoperative blood loss

    Measured: Immediate postoperatively

  8. Surgical incision length

    Measured: Immediate postoperatively

  9. Postoperative hospital stay

    Measured: Immediate postoperatively

  10. Perioperative complication rate

    Measured: Immediate postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2024
  2. Study start8 Dec 2024
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
324 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06719037
Sponsor's protocol ID
KYLL-202208-046-1
Status last verified
Nov 2024
First submitted
18 Nov 2024
Last updated
7 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Han S, Zeng X, Zhu K, Wu X, Shen Y, Han J, Lin A, Meng S, Zhang H, Li G, Liu X, Tao H, Ma X, Zhou C. Clinical Application of Large Channel Endoscopic Systems with Full Endoscopic Visualization Technique in Lumbar Central Spinal Stenosis: A Retrospective Cohort Study. Pain Ther. 2022 Dec;11(4):1309-1326. doi: 10.1007/s40122-022-00428-3. Epub 2022 Sep 3.

    PubMed 36057015
  • Katz JN, Zimmerman ZE, Mass H, Makhni MC. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022 May 3;327(17):1688-1699. doi: 10.1001/jama.2022.5921.

    PubMed 35503342
  • Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022.

    PubMed 36511921
  • Ghogawala Z, Dziura J, Butler WE, Dai F, Terrin N, Magge SN, Coumans JV, Harrington JF, Amin-Hanjani S, Schwartz JS, Sonntag VK, Barker FG 2nd, Benzel EC. Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis. N Engl J Med. 2016 Apr 14;374(15):1424-34. doi: 10.1056/NEJMoa1508788.

    PubMed 27074067
  • Forsth P, Olafsson G, Carlsson T, Frost A, Borgstrom F, Fritzell P, Ohagen P, Michaelsson K, Sanden B. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis. N Engl J Med. 2016 Apr 14;374(15):1413-23. doi: 10.1056/NEJMoa1513721.

    PubMed 27074066

Questions about this trial

What is this clinical trial studying?

A study testing Endo-Surgi Plus endoscopic surgery, Unilateral biportal endoscopic surgery and Microdiscectomy in people with Lumbar Spinal Stenosis, run by Qilu Hospital of Shandong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xinyu Yang, M.D. (+8618560089496, dr_xinyuyang@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Oswestry Disability Index scores (time frame: 1 year postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06719037, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in